Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-09-30, Stock:JNJ, The news for the past five days is as follows:
2019-09-23: NEWS1: Getting technical on a Dow 30,000 call.NEWS2: Long-Term Investors Should Consider Buying SHOP Stock Near $250.NEWS3: UPDATE 1-Aid group says vaccine 'rationing' in Congo is hampering Ebola fight.NEWS4: Fast-growing Atlanta biomedical company hires new CEO.NEWS5: Atlanta biomedical company hires second new CEO in less than a year.NEWS6: Dow flat despite losses for shares of Dow Inc., UnitedHealth.NEWS7: Aid group says WHO is restricting access to Ebola vaccines in Congo.NEWS8: FDA Warns About Safety of Breast Implant: 3 Stocks at Risk (Revised).
2019-09-24: NEWS1: Johnson & Johnson (JNJ) Stock Moves -0.14%: What You Should Know.NEWS2: 5 Stocks That Could Get Crushed By Opioid Lawsuit Tidal Wave.NEWS3: quot;Healthyquot; Dividend Aristocrats: 6 Great Health-Care Dividends.NEWS4: AstraZeneca Gets CHMP Nod for Forxiga/Onglyza Combo Tablet.NEWS5: Fast-growing Atlanta biomedical company hires new CEO.NEWS6: Mallinckrodt's StrataGraft Tissue Phase III Data Positive.
2019-09-25: NEWS1: Major indexes mixed with Trump memo out.
2019-09-26: NEWS1: US Indexes Close Lower Thursday.NEWS2: CHS, other Tennessee hospitals file lawsuit against opioid companies.NEWS3: Saint Thomas, CHS hospitals file lawsuit against opioid companies.NEWS4: Foreign Firms Recognized as Hottest Biotechs.NEWS5: UnitedHealth, Chevron share losses lead Dow's 64-point drop.NEWS6: 10 Biggest Companies That Offer Pensions.NEWS7: Opioid Overdose Crisis in US Likely to Affect These 3 Stocks.NEWS8: The Daily Biotech Pulse: Enanta Aces Midstage NASH Study, Takeda's Ulcerative Colitis Drug Found Superior To AbbVie's, Decision Day For J&J.
2019-09-27: NEWS1: The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave.

Answer: Rise